| |
NOW YOU CAN ORDER FDA APPROVED SLEEP AID MEDICATION ONLINE! CLICK HERE TO ORDER IT NOW!Introducing...Rozerem - an FDA approved sleep aid -, a
new development in sleep aid therapy. To learn more, please read the prescribing
information.
What purpose
does sleep serve in our lives? Is it to
refresh the body-or is it to recharge the mind? Experts aren't sure,
but something we can all agree on is that sleep is essential for
everyone. Exciting advances in neuroscience have provided insight
into how the sleep cycle is regulated, which has led to new
treatment options for insomnia.
What happens when we sleep Alternating periods of activity and rest are
synchronized with the 24-hour cycle of daylight and darkness. This
is called the sleep-wake cycle, and it is regulated by the body's
internal master clock, located in the suprachiasmatic nucleus
(SCN). 1 The SCN is believed to
be important in sleep and wakefulness.2
More >

What happens when
we don't sleep The inability to sleep
doesn't just disrupt the sleeping hours. Insomnia affects the waking
hours as well and has been associated with depression, decreased
productivity and quality of life, and an increased risk for
accidents. 3 More >

Rozerem - an FDA approved sleep aid - is indicated for the treatment of
insomnia characterized by difficulty with sleep onset. Rozerem - an FDA approved sleep aid -
should not be used in patients with hypersensitivity to ramelteon or
any components of the formulation. Rozerem - an FDA approved sleep aid - can be prescribed for
long-term use. However, failure of insomnia to remit after a
reasonable period of time, worsening of insomnia, or the emergence
of new cognitive or behavioral abnormalities after taking Rozerem - an FDA approved sleep aid -
should be evaluated, as such symptoms may be the result of an
unrecognized underlying medical disorder. In primarily depressed
patients, worsening of depression, including suicidal ideation, has
been reported in association with the use of
hypnotics.
Rozerem - an FDA approved sleep aid - should not be used by patients with severe
hepatic impairment, or in patients in combination with fluvoxamine.
Rozerem - an FDA approved sleep aid - has not been studied in subjects with severe sleep
apnea or severe COPD and is not recommended for use in those
populations. Patients should be advised to exercise caution if they
consume alcohol in combination with Rozerem - an FDA approved sleep aid -.
Rozerem - an FDA approved sleep aid - has
been associated with decreased testosterone levels and increased
prolactin levels. As a result, healthcare professionals should be
mindful of any unexplained symptoms possibly associated with such
changes in these hormone levels. Rozerem - an FDA approved sleep aid - has not been studied in
children or adolescents, and the effects in these populations are
unknown.
Rozerem - an FDA approved sleep aid - should be taken within 30 minutes before
going to bed and activities should be confined to those necessary to
prepare for bed. Rozerem - an FDA approved sleep aid - should not be taken with or immediately
after a high-fat meal. Engaging in hazardous activities that require
concentration (such as operating a motor vehicle or heavy machinery)
after taking Rozerem - an FDA approved sleep aid - should be avoided.
The most common
adverse events seen with Rozerem - an FDA approved sleep aid - that had greater than 2% incidence
difference from placebo were somnolence, dizziness, and fatigue.
References:
1. Turek FW, Dugovic C, Zee PC. Current understanding of
the circadian clock and the clinical implications for neurological
disorders. Arch Neurol. 2001;58:1781-1787.
2. Edgar DM, Dement WC, Fuller CA. Effect of SCN
lesions on sleep in squirrel monkeys: evidence for opponent
processes in sleep-wake regulation. J Neurosci.
1993;13:1065-1079. 3. Roth T, Roehrs T.
Insomnia: epidemiology, characteristics, and consequences. Clin
Cornerstone. 2003;5:5-15.

|